Keyphrases
Immune Checkpoint Genes
100%
DNA Methylation (DNAm)
100%
Aryl Hydrocarbon Receptor
100%
Colon Cancer Stem Cells
100%
Omani
100%
Cancer Stem Cells
100%
Qatari
100%
Immune Checkpoint
50%
Colorectal Cancer
50%
Aryl Hydrocarbon Receptor Pathway
25%
Cytotoxic T-lymphocyte-associated Protein 4 (CTLA-4)
25%
Human Colon Cancer
25%
Chemoresistance
25%
Immune Checkpoint Pathway
25%
Colon Tissue
25%
Self-renewal
25%
Cancer Development
25%
Colon Cancer
25%
Qatar
25%
Novel Biomarkers
25%
Treatment Regimen
12%
Aggressiveness
12%
Caco-2
12%
Cancer Recurrence
12%
LS174T
12%
Receptor Activation
12%
Constitutive Expression
12%
Cell Development
12%
Metastasis Prognosis
12%
Annual Incidence
12%
Cancer Resistance
12%
Lung Cancer
12%
Tumor Initiation
12%
Inducible Expression
12%
Colon Surgery
12%
Neoplasms
12%
Stem Cell Proliferation
12%
Cancer Treatment
12%
Breast
12%
Effective Treatment
12%
Prostate Cancer
12%
Advanced Stage
12%
In Cancer
12%
Human-based
12%
Novel Therapeutic Targets
12%
Early Detection
12%
Breast Cancer
12%
Programmed Death-ligand 1 (PD-L1)
12%
In Vitro Study
12%
Immunofluorescence
12%
Cancer Cell Lines
12%
Recent Advances
12%
HCT116
12%
SW480
12%
Tissue Sampling
12%
Anticancer Drugs
12%
Cancer Mortality
12%
Existing Challenges
12%
Cancer Causes
12%
Poor Prognosis
12%
Targeted Therapy
12%
Colon
12%
Blood Samples
12%
Oman
12%
INIS
genes
100%
in vitro
100%
receptors
100%
stem cells
100%
colon
100%
patients
100%
cancer
100%
aryl hydrocarbons
100%
dna
100%
methylation
100%
humans
10%
therapy
6%
tissues
6%
qatar
6%
hypothesis
6%
breasts
6%
biological markers
6%
inhibition
6%
Medicine and Dentistry
In Vitro
100%
Cancer Stem Cell
100%
Colon Cancer
100%
Clinical Study
100%
DNA Methylation
100%
Aromatic Hydrocarbon Receptor
100%
Colorectal Cancer
36%
Malignant Neoplasm
36%
Biological Marker
18%
Cancer Tissue
18%
CTLA-4
18%
Drug Resistance
18%
Metastatic Carcinoma
9%
Cancer Therapy
9%
Lung Cancer
9%
Cell Proliferation
9%
Cancer Recurrence
9%
Prostate Cancer
9%
Cell Maturation
9%
Targeted Therapy
9%
Cancer Treatment
9%
Immunofluorescence
9%
Anticarcinogen
9%
Breast Cancer
9%
Cancer Cell Line
9%
Colon
9%
Tumor Initiation
9%
Caco-2
9%
Cancer Resistance
9%
Neoplasm
9%